X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9901) 9901
Publication (583) 583
Book Review (240) 240
Book Chapter (85) 85
Newsletter (34) 34
Magazine Article (27) 27
Newspaper Article (12) 12
Book / eBook (10) 10
Conference Proceeding (6) 6
Dissertation (3) 3
Reference (3) 3
Web Resource (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8563) 8563
female (4363) 4363
index medicus (4004) 4004
male (3647) 3647
anticoagulants - therapeutic use (3044) 3044
heparin (2977) 2977
anticoagulants - adverse effects (2875) 2875
molecular-weight heparin (2842) 2842
middle aged (2791) 2791
aged (2640) 2640
heparin - adverse effects (2238) 2238
hematology (2060) 2060
adult (2053) 2053
anticoagulants (2032) 2032
heparin, low-molecular-weight - therapeutic use (2013) 2013
risk factors (1910) 1910
thrombosis (1718) 1718
anticoagulants - administration & dosage (1708) 1708
heparin, low-molecular-weight - adverse effects (1688) 1688
peripheral vascular disease (1675) 1675
treatment outcome (1583) 1583
unfractionated heparin (1551) 1551
venous thromboembolism (1531) 1531
heparin - therapeutic use (1520) 1520
thromboembolism (1422) 1422
prevention (1380) 1380
surgery (1360) 1360
deep-vein thrombosis (1315) 1315
thrombocytopenia - chemically induced (1297) 1297
hemorrhage - chemically induced (1119) 1119
heparin, low-molecular-weight - administration & dosage (1083) 1083
cardiac & cardiovascular systems (1032) 1032
aged, 80 and over (1011) 1011
enoxaparin (1008) 1008
pregnancy (976) 976
heparin - administration & dosage (955) 955
fibrinolytic agents - therapeutic use (881) 881
anticoagulation (844) 844
medicine, general & internal (840) 840
retrospective studies (835) 835
prospective studies (817) 817
pharmacology & pharmacy (811) 811
venous thrombosis - prevention & control (796) 796
thromboembolism - prevention & control (790) 790
medicine & public health (771) 771
drug therapy (764) 764
animals (744) 744
prophylaxis (737) 737
warfarin (735) 735
heparin-induced thrombocytopenia (730) 730
therapy (722) 722
care and treatment (719) 719
time factors (713) 713
risk (711) 711
venous thromboembolism - prevention & control (701) 701
pulmonary-embolism (698) 698
postoperative complications - prevention & control (693) 693
venous thrombosis (664) 664
pulmonary embolism (663) 663
health aspects (630) 630
fibrinolytic agents - adverse effects (611) 611
thrombocytopenia (611) 611
management (601) 601
analysis (600) 600
thrombosis - prevention & control (597) 597
glycosaminoglycans (596) 596
risk assessment (596) 596
venous thrombosis - drug therapy (594) 594
complications (565) 565
low-molecular-weight heparin (557) 557
aspirin (536) 536
low molecular weight heparin (529) 529
diagnosis (527) 527
thromboprophylaxis (511) 511
venous thrombosis - etiology (508) 508
randomized controlled trials as topic (505) 505
incidence (501) 501
dose-response relationship, drug (488) 488
enoxaparin - therapeutic use (477) 477
abridged index medicus (473) 473
adolescent (472) 472
risk-factors (470) 470
mortality (469) 469
enoxaparin - adverse effects (463) 463
research (457) 457
drug administration schedule (447) 447
warfarin - therapeutic use (440) 440
platelet aggregation inhibitors - therapeutic use (439) 439
cancer (438) 438
anticoagulants - pharmacology (432) 432
pulmonary embolism - prevention & control (424) 424
venous thromboembolism - etiology (420) 420
blood coagulation - drug effects (418) 418
cardiology (417) 417
fibrinolytic agents - administration & dosage (405) 405
thrombosis - etiology (395) 395
antibodies (394) 394
bleeding (393) 393
follow-up studies (387) 387
administration, oral (384) 384
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9385) 9385
German (219) 219
French (217) 217
Spanish (77) 77
Chinese (22) 22
Russian (17) 17
Japanese (13) 13
Dutch (12) 12
Italian (12) 12
Polish (12) 12
Norwegian (11) 11
Hungarian (10) 10
Swedish (10) 10
Danish (9) 9
Czech (7) 7
Portuguese (7) 7
Croatian (6) 6
Turkish (5) 5
Serbian (4) 4
Slovak (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 05/2008, Volume 99, Issue 5, pp. 807 - 818
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 7, pp. 615 - 624
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 4/2012, Volume 18, Issue 2, pp. 159 - 165
Journal Article
Journal Article
by Schulman, Sam and Kakkar, Ajay K and Goldhaber, Samuel Z and Schellong, Sebastian and Eriksson, Henry and Mismetti, Patrick and Christiansen, Anita Vedel and Friedman, Jeffrey and Le Maulf, Florence and Peter, Nuala and Kearon, Clive and Schulman, S and Eriksson, H and Goldhaber, S and Kakkar, A and Kearon, C and Mismetti, P and Schellong, S and Bergqvist, D and Tijssen, J and Prins, M. [=Martin H.] and Robben, S and Büller, H and Otten, H. M and Brandjes, D and Peters, R and Mac Gillavry, M. R and Gan, E and Salem, H and Baker, R and Blomberry, P and Curnow, J and Annichino-Bizzacch, J. M and Brandao Panico, M. D and Timi Ribas, J. R and Fernandes Manenti, E. R and Miranda, F and Moraes, J and Raev, D and Mollov, M and Peneva, M and Milanov, S and Anderson, D and Crowther, M and Dolan, S and Eikelboom, J and Game, M and Kahn, S and Kassis, J and Ritchie, B and Solymoss, S and Rodger, M and Yeo, E and Milot, A and Klinke, P and Chen, W and Zhihong, L and Chunxue, B and Jinming, L and Jiwei, Z and Jie, C and Jina, K and Yuqi, W and Zhongqi, Y and Hua, W and Kejing, Y and Bonan, L and Yadong, Y and Changwei, L and Jin, Z and Yongcheng, D and Spinar, J and Maly, R and Cizek, V and Bercikova, J and Cervinka, P and Lang, P and Jirka, V and Oral, I and Reichert, P and Kotik, L and Pojsl, S and Klimovic, T and Husted, S and Nielsen, H and Friis, E and Skødebjerg Kristensen, K and Mottier, D and El Kouri, D and Bleher, Y and Leroux, L and Boda, Z and Sereg, M and Riba, M and Hiremath, J. S and Kareem, S and Banker, D. N and Gadkari, M and Parakh, R and Suresh, K. R and ... and RE-COVER II Trial Investigators
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e24S - e43S
This article describes the pharmacology of approved parenteral anticoagulants. These include the indirect anticoagulants, unfractionated heparin (UFH),... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heparitin Sulfate - adverse effects | United States | Humans | Thrombin - antagonists & inhibitors | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Pipecolic Acids - administration & dosage | Chondroitin Sulfates - adverse effects | Societies, Medical | Pipecolic Acids - adverse effects | Heparitin Sulfate - administration & dosage | Polysaccharides - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Evidence-Based Medicine | Recombinant Proteins - administration & dosage | Antithrombins - agonists | Chondroitin Sulfates - administration & dosage | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Thrombosis - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Practice Guidelines as Topic | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 6, Issue 6, p. CD009447
Background The choice of the appropriate perioperative thromboprophylaxis in patients with cancer depends on the relative benefits and harms of low molecular... 
Hemorrhage [chemically induced] | COLORECTAL SURGERY | CONTROLLED-TRIAL | GENERAL-SURGERY | SURGICAL-PATIENTS | Postoperative Complications [mortality; prevention & control] | LOW-DOSE HEPARIN | Humans | Heparin [administration & dosage; adverse effects] | FATAL PULMONARY-EMBOLISM | DEEP-VEIN THROMBOSIS | GYNECOLOGIC ONCOLOGY | Thrombocytopenia [prevention & control] | Heparin, Low-Molecular-Weight [administration & dosage; adverse effects] | Thrombosis [mortality prevention & control] | Venous Thrombosis [prevention & control] | MEDICINE, GENERAL & INTERNAL | Anticoagulants [administration & dosage; adverse effects] | Neoplasms [mortality; surgery] | Pulmonary Embolism [prevention & control] | POSTOPERATIVE VENOUS THROMBOEMBOLISM | DOUBLE-BLIND | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Neoplasms - surgery | Postoperative Complications - prevention & control | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Neoplasms - mortality | Postoperative Complications - mortality | Anticoagulants - adverse effects | Heparin - adverse effects | Randomized Controlled Trials as Topic | Thrombocytopenia - prevention & control | Venous Thrombosis - prevention & control | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Thrombosis - prevention & control | Thrombosis - mortality
Journal Article